International journal of pediatric otorhinolaryngology最新文献

{"title":"Pediatric acute mastoiditis severity – Can inflammatory biomarkers help us?","authors":"Roye Mauthner , Tal Marom , Ayala Klein , Yuval Mizrakli , Sharon Ovnat Tamir","doi":"10.1016/j.ijporl.2025.112405","DOIUrl":"10.1016/j.ijporl.2025.112405","url":null,"abstract":"","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"195 ","pages":"Article 112405"},"PeriodicalIF":1.2,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144178141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hearing and neurodevelopmental outcomes among children with congenital cytomegalovirus","authors":"Jordan C. Stout ,&nbsp;Jessica Leung ,&nbsp;Peter Kfoury ,&nbsp;John A. Germiller ,&nbsp;Albert H. Park ,&nbsp;Tatiana M. Lanzieri","doi":"10.1016/j.ijporl.2025.112408","DOIUrl":"10.1016/j.ijporl.2025.112408","url":null,"abstract":"<div><h3>Objective</h3><div>Congenital cytomegalovirus (cCMV) infection is the most common congenital infection and the leading non-genetic cause of sensorineural hearing loss. We assessed demographics, clinical characteristics, hearing and neurodevelopmental outcomes by 6 years of age among U.S. children with possible cCMV.</div></div><div><h3>Study design</h3><div>Retrospective cohort design.</div></div><div><h3>Setting</h3><div>The Audiological and Genetic Database (AudGenDB) includes 175,216 pediatric patients who underwent audiology, otology or genetic visits during 2006–2019 in Children's Hospital of Philadelphia, Vanderbilt Children's Hospital, or Boston Children's Hospital.</div></div><div><h3>Methods</h3><div>Children with possible cCMV were identified by diagnostic codes for cCMV infection and CMV disease up to 6 years of age. We examined clinical signs of cCMV during 0–45 days of birth and neurodevelopmental conditions (including hearing loss) up to 6 years of age. Hearing loss was defined as pure tone average or any frequency threshold ≥25 dB.</div></div><div><h3>Results</h3><div>A total of 180 (0.1 %) children with possible cCMV were identified; 70 % had diagnosis codes after 45 days of life. The proportions of Black and Hispanic/Latino children comprised a higher proportion in the possible cCMV group compared to the non-cCMV group. Overall, 129 (72 %) children with possible cCMV had diagnoses codes for neurodevelopmental conditions, including hearing loss (56), communication delays (45) and cerebral palsy (22). Hearing loss was diagnosed at a median age of 2 (1–4) years.</div></div><div><h3>Conclusion</h3><div>Neurodevelopmental delays were common among children with possible cCMV included in this study. AudGenDB provides access to longitudinal outcomes for a large and diverse cohort that remains helpful in lieu of state-mandated screenings.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"195 ","pages":"Article 112408"},"PeriodicalIF":1.2,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144178143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Should we still consider lateral neck radiography in the evaluation of adenoid hypertrophy? A systematic review and meta-analysis","authors":"Abdulsalam Alqutub ,&nbsp;Reema D. AlGhamdi ,&nbsp;Lojain M. Maawadh ,&nbsp;Sadeem J. Almoajil ,&nbsp;Ziyad M. Alqahtani ,&nbsp;Abdullah A. Bamousa ,&nbsp;Abdulmalik Abumohssin ,&nbsp;Abeer Z. Malebari ,&nbsp;Talal Al-Khatib","doi":"10.1016/j.ijporl.2025.112389","DOIUrl":"10.1016/j.ijporl.2025.112389","url":null,"abstract":"<div><h3>Background</h3><div>Adenoid hypertrophy is a common childhood disorder that can lead to significant symptoms and complications. Early diagnosis and management are crucial for improving patient outcomes. While endoscopy is the gold standard for diagnosis, its invasiveness and cost are limiting factors. Lateral neck radiography may serve as an effective alternative for evaluating adenoid hypertrophy. This study aims to assess the role of X-rays in diagnosing and grading adenoid hypertrophy.</div></div><div><h3>Methods</h3><div>From inception to October 2024, we conducted an extensive literature search across four databases on studies using X-rays to evaluate adenoidal hypertrophy, with endoscopy as a reference test. We calculated the sensitivity (SN) and specificity (SP) for each study and pooled the results in a random-effects meta-analysis model.</div></div><div><h3>Results</h3><div>Our systematic review included 50 studies involving 12266 patients with adenoid hypertrophy. The pooled analysis revealed a SN of 0.751 and SP of 0.893 for lateral neck radiography in diagnosing mild adenoid hypertrophy. However, these values slightly decreased for moderate and severe adenoid hypertrophy, with a pooled SN of 0.618 and SP of 0.714 for moderate adenoid hypertrophy and a pooled SN of 0.637 and SP of 0.834 for severe adenoid hypertrophy.</div></div><div><h3>Conclusion</h3><div>Our study demonstrates moderate sensitivity and specificity of lateral neck radiography for diagnosing mild adenoid hypertrophy while also highlighting its diagnostic limitations for moderate and severe adenoid enlargement. Clinical evaluation and nasopharyngoscopy remain the optimal diagnostic modalities in evaluating adenoid hypertrophy.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"195 ","pages":"Article 112389"},"PeriodicalIF":1.2,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144178140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The efficacy of auto-inflation in children with chronic otitis media with effusion","authors":"Haigang Zhang,&nbsp;Mingyue Fan,&nbsp;Xinghe Zhao,&nbsp;Yaxuan Fang,&nbsp;Xunwu Dou","doi":"10.1016/j.ijporl.2025.112403","DOIUrl":"10.1016/j.ijporl.2025.112403","url":null,"abstract":"<div><h3>Objective</h3><div>To explore the efficacy of auto-inflation in children with chronic otitis media with effusion.</div></div><div><h3>Method</h3><div>Clinical data of 81 children (157 ears) with chronic otitis media with effusion treated in our hospital from December 2023 to November 2024 were collected. There are 37 males and 44 females, aged between 3.67 and 14.42 years old, with an average of 7.37 ± 2.68 years old. 71 cases complained of otalgia, 8 cases of hearing loss, 1 case of ear fullness, and 1 case of recurrent otitis media after grommet insertion. All patients underwent 3 months of conservative treatment.</div></div><div><h3>Result</h3><div>The changes in hearing thresholds before and after auto-inflation exhibited distinct frequency-specific characteristics, with the lowest hearing loss observed at 2000 Hz, which was significantly lower than that at 1000 Hz and 4000 Hz (P &lt; 0.05, statistically significant difference). The pure-tone audiometry of pre-treatment evaluation (P-TE) was 26.61 ± 11.553 dB. At 2 weeks, 4 weeks, 8 weeks, 12 weeks, and termination of treatment, the pure-tone audiometry were 15.63 ± 10.308, 14.37 ± 5.508, 16.62 ± 13.273, 12.11 ± 7.315, 13.82 ± 8.520 dB, respectively. Compared with P-TE, the difference was statistically significant (<em>P</em> &lt; 0.05). The P-value was &lt;0.05, indicating statistically significant differences. For P-TE, 78.344 % (123/157) of patients exhibited a Type B tympanogram. At 2 weeks, 4 weeks, 8 weeks, 12 weeks, and at the terminating evaluation (TE), the proportions were 22.472 % (20/89), 21.533 % (14/65), 14.815 % (8/54), 3.448 % (1/20), and 11.765 % (18/153), respectively. Compared with P-TE, the difference was statistically significant (<em>P</em> &lt; 0.05). After 12 weeks of standardized treatment, <strong>22.93 % (36/157)</strong> of otitis media cases achieved complete resolution, <strong>74.52 % (117/157)</strong> showed clinical improvement, and <strong>2.55 % (4/157)</strong> had no therapeutic response. Otalgia was the only adverse reaction (3.7 %, 3/81) and can be relieved.</div></div><div><h3>Conclusions</h3><div>Auto-inflation is effective in children with COME, with rapid results and minimal adverse reactions.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"194 ","pages":"Article 112403"},"PeriodicalIF":1.2,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effectiveness of parent participation in postoperative pain management programs for children undergoing tonsillectomy: an experimental controlled study","authors":"Jin-Xia Yang ,&nbsp;Jian-Min Zhang ,&nbsp;Yue Liu ,&nbsp;Yun-Feng Zhou ,&nbsp;Fang Zhang ,&nbsp;Wen-Ying Yao ,&nbsp;Zi-Sheng Ai ,&nbsp;Dao-Ping Yang","doi":"10.1016/j.ijporl.2025.112399","DOIUrl":"10.1016/j.ijporl.2025.112399","url":null,"abstract":"<div><h3>Purpose</h3><div>Tonsillectomy is one of the most common surgical procedures, with 289,000 ambulatory procedures performed annually in children &lt;15 years of age, and pain is a major cause of post-tonsillectomy complications. We sought to evaluate the effect of parent participation in postoperative pain management programs on children's post-tonsillectomy pain score and other outcome measures.</div></div><div><h3>Methods</h3><div>Parent participation in postoperative pain management programs was based on the quality improvement model developed by the Evidence-Based Nursing Center of Fudan University and validated among child urological patients. This between-group experimental controlled study was conducted in the inpatient ENT ward of a tertiary children's hospital. The control group comprised 118 children randomly selected from April 1 to May 15, 2022, and the experimental group included 117 children randomly selected from June 1 to July 15, 2022. To evaluate the effectiveness of the model, the control group received routine postoperative pain management, and the intervention group received the program of parental involvement in postoperative pain management. Postoperative pain-related data were collected for the two groups of children.</div></div><div><h3>Results</h3><div>There was no significant difference in the demographic characteristics of the two groups of children (<em>P</em> &gt; 0.05). The pain score of the children in the intervention group was significantly lower than that of the control group when returning to the ward on the day of surgery (<em>Z</em> = 3.185, <em>P</em> = 0.002), after 2 h (<em>Z</em> = 7.280, <em>P&lt;</em>0.001), after 4 h (<em>Z</em> = 6.4000, <em>P&lt;</em>0.001), after 24 h (<em>Z</em> = 2.698, <em>P</em> = 0.009), at discharge (<em>Z</em> = 3.397, <em>P</em> = 0.002), and at the postoperative hospital visit (<em>Z</em> = 3.349, <em>P</em> = 0.001). There were no significant differences in the pain score at 02:00 in the morning after the operation or effective sleep time after the operation between the two groups (<em>P</em> &gt; 0.05).</div></div><div><h3>Conclusions</h3><div>and Clinical Im<strong>plications</strong>: Programs of parental participation in postoperative pain management applied to children undergoing tonsillectomy can improve the participation of parents in postoperative pain management of children, relieve postoperative pain in children undergoing tonsillectomy, and improve children's postoperative quality of life.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"195 ","pages":"Article 112399"},"PeriodicalIF":1.2,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144178142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quality of life after combined adenoidectomy and laser tonsillotomy for pediatric sleep-disordered breathing: A prospective observational cohort trial","authors":"Katharina Geißler,&nbsp;Marie Höppner,&nbsp;Thomas Bitter,&nbsp;Orlando Guntinas-Lichius","doi":"10.1016/j.ijporl.2025.112402","DOIUrl":"10.1016/j.ijporl.2025.112402","url":null,"abstract":"<div><h3>Introduction</h3><div>Tonsillotomy is an alternative to tonsillectomy with much less morbidity in case of tonsil surgery for pediatric sleep-disordered breathing (PSDB), but tonsillar disease-specific quality of life data conforming the effectiveness are sparse.</div></div><div><h3>Methods</h3><div>A prospective observation study was conducted in children with PSDB undergoing laser (adeno)tonsillotomy. A German version Tonsil and Adenoid Health Status Instrument (TAHSI) for the children (G-TAHSI-c), for the parents (G-TAHSI-p), and the Tonsillectomy Outcome Inventory 14 (TOI-14) were measured before surgery (T0), 3 months (T3), and 6 months (T6) after surgery.</div></div><div><h3>Results</h3><div>54 children (65 % male; median age: 4 years; 96.3 % combined adenotonsillotomy) were included. The G-TAHSI-c subdomains eating/swallowing, halitosis, work performance, and the total score improved significantly between T0 and T3 (all p &lt; 0.05). The subdomains recurrent throat infections, chronic throat infections, lymphadenopathy, health utilization, and nocturnal breathing did not change significantly (all p &gt; 0.05). The G-TAHSI-p subdomains chronic throat infections, eating and swallowing problems, halitosis, severe throat infections, and the total G-TAHSI-p improved (all p &lt; 0.05). All subdomains but the TOI-14 subdomain social psychological restrictions and the total score improved significantly from T0 to T3 (all p &lt; 0.05). A significant further change between T3 and T6 was not seen for G-TAHSI-c, G-TAHSI-p, and TOI-14 (all p &gt; 0.05). Gender, age, and initial OSA-18 score had no influence on the quality of life improvement.</div></div><div><h3>Conclusions</h3><div>(Adeno)tonsillotomy leads to fast quality of life improvement in children with PSDB within 3 months after surgery.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"194 ","pages":"Article 112402"},"PeriodicalIF":1.2,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144131726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of sleep structure and clinical characteristics between REM-related OSA and non- REM-related OSA in children","authors":"ChenXi Luo,&nbsp;WenBo Chen,&nbsp;Qi Li","doi":"10.1016/j.ijporl.2025.112395","DOIUrl":"10.1016/j.ijporl.2025.112395","url":null,"abstract":"<div><h3>Objective</h3><div>To measure the prevalence of REM-related OSA(rapid eye movement related obstructive sleep apnea) in children and describe and compare the demographics, clinical features, and sleep structure characteristics of REM-related OSA compared to non-REM-related OSA(no rapid eye movement related obstructive sleep apnea).</div></div><div><h3>Methods</h3><div>Data were collected from 569 children at the Sleep Center of the Department of Otorhinolaryngology, Nanjing Children's Hospital. Physical examinations were performed, and all participants completed polysomnography (PSG) monitoring. Clinical characteristics and PSG data were compared between children with REM-related OSA and those with non-REM-related OSA.</div></div><div><h3>Results</h3><div>The prevalence of REM-related OSA in children was 43.4 %. Children with REM-related OSA were more likely to be female compared to those with non-REM-related OSA (P = 0.015). N1(non-rapid eye movement sleep stage 1) sleep duration was shorter (P &lt; 0.001), and SpO2 during REM periods was lower (P &lt; 0.001) in REM-related OSA children compared to non-REM-related OSA children. The prevalence of P-OSA(positional obstructive sleep apnea)was higher in the REM-related OSA group. Female sex and P-OSA were identified as independent risk factors for REM-related OSA.</div></div><div><h3>Conclusion</h3><div>The prevalence of REM-related OSA was 43.4 %. Female sex and P-OSA are independent risk factors for REM-related OSA. These findings provide a basis for future personalized treatment strategies for OSA in children.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"194 ","pages":"Article 112395"},"PeriodicalIF":1.2,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144115308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What works for whom? A systematic review on personalized speech intervention in children and adolescents with a cleft palate","authors":"Cassandra Alighieri ,&nbsp;Febe Vandewiele ,&nbsp;Valerie Pereira","doi":"10.1016/j.ijporl.2025.112401","DOIUrl":"10.1016/j.ijporl.2025.112401","url":null,"abstract":"<div><h3>Objective</h3><div>Personalized health care involves intervention that is tailored to the unique characteristics of the individual. Even though personalized interventions have gained more attention in the past decades, this topic has not yet been systematically studied in the area of speech and language intervention in children with a cleft (lip and) palate (CP ± L). The aim of this systematic review is to summarize the evidence of the effects of personalized speech intervention in children with a CP ± L, aged 3–18 years, with a narrow focus on anterior oral, posterior oral, and non-oral cleft speech characteristics.</div></div><div><h3>Methods</h3><div>This systematic literature review was developed following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via PubMed), and Embase were searched and the grey literature was checked. The search strategy was based on three concepts: cleft palate, speech intervention, and children. Two raters independently determined the eligibility and extracted all relevant data from the included studies. The methodological quality of the included study was also assessed using the QualSyst tool.</div></div><div><h3>Results</h3><div>Four studies were included in this review. The overall quality of the included studies was good. Children with severe, non-oral cleft speech characteristics were found to benefit from motor-phonetic based intervention strategies. Linguistic-phonological strategies, in contrast, were more effective in improving speech and health-related quality of life in children with less severe, anterior oral or posterior oral cleft speech characteristics.</div></div><div><h3>Conclusion</h3><div>There is some evidence that personalized speech intervention yields better outcomes than a “one-size-fits-all” approach. Further research, especially randomized (sham-)controlled trials, is necessary to confirm these results.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"194 ","pages":"Article 112401"},"PeriodicalIF":1.2,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144115204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ketorolac does not increase postoperative hemorrhage and limits narcotic use in pediatric patients undergoing intracapsular tonsillectomy","authors":"Elizabeth D. Fisher ,&nbsp;Julia GM. Carter ,&nbsp;Michelle Tsao ,&nbsp;John Maddalozzo ,&nbsp;Douglas Johnston","doi":"10.1016/j.ijporl.2025.112400","DOIUrl":"10.1016/j.ijporl.2025.112400","url":null,"abstract":"<div><h3>Background</h3><div>Conflicting evidence regarding the safety of perioperative ketorolac in children undergoing intracapsular tonsillectomy has led to some providers avoiding the use of ketorolac. However, emerging evidence indicates that ketorolac may be a safe option for pain control in these patients.</div></div><div><h3>Methods</h3><div>We conducted a single-center retrospective cohort study of children undergoing intracapsular tonsillectomy. Exposures were children who received perioperative pain control with ketorolac compared to children who did not receive perioperative pain control with ketorolac. The primary study outcome was post tonsillectomy hemorrhage (PTH) requiring operative control. Secondary outcomes were post operative pain readmission, time spent in the PACU, and opioids administered in the PACU.</div></div><div><h3>Results</h3><div>1594 patients fit inclusion criteria; 743 received ketorolac (46.6 %) and 851 did not receive ketorolac (53.4 %). There was no difference in rate of PTH requiring operative control in patients who received ketorolac compared to patients who did not (0.7 % vs 1.4 %, Chi-square test, p = 0.1415). There was no difference in the rate of postoperative pain readmission between the two groups (2.0 % vs 3.1 %, Mid-P test, p = 0.167). The median time spent in the PACU was 13.4 % less in the ketorolac group (48 min vs 58 min, multivariate linear regression, p &lt; 0.001). The mean total opioid dose given in the PACU was significantly less in the ketorolac group (3.7 morphine milligram equivalents (MME) vs 5.3 MME, <em>t</em>-test, p &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>In this cohort of children undergoing intracapsular tonsillectomy, there was no difference in the rate of PTH requiring operative control in children who received perioperative ketorolac compared to children who did not receive perioperative ketorolac. In addition, children who received ketorolac received lower total amonuts of opioids in the perioperative period and spent less time in the PACU. Further prospective, randomized clinical trials are necessary to confirm the impact of ketorolac in this population.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"195 ","pages":"Article 112400"},"PeriodicalIF":1.2,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144178144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of two coagulation techniques for the control of pediatric recurrent anterior epistaxis with allergic rhinitis: Semi-randomized clinical trial","authors":"Zhengcai Lou ,&nbsp;Zihan Lou ,&nbsp;Zhengnong Chen","doi":"10.1016/j.ijporl.2025.112394","DOIUrl":"10.1016/j.ijporl.2025.112394","url":null,"abstract":"<div><h3>Objective</h3><div>To compare the long-term outcomes, postoperative pain, and complications of bipolar electrocautery (BEC) and radiofrequency coagulation (RFC) in the treatment of pediatric patients with recurrent anterior epistaxis (RAE) and allergic rhinitis (AR).</div></div><div><h3>Materials and methods</h3><div>Children presenting with RAE and AR were prospectively semi-randomized to receive BEC or RFC during the 2-year period. We recorded the occurrence of recurrent epistaxis as well as epistaxis severity scores (ESSs) and visual analogue scale (VAS) scores for AR-related symptoms.</div></div><div><h3>Results</h3><div>In total, 67 children were included: 34 in the BEC group and 33 in the RFC group. The recurrent <em>epistaxis</em> rate was significantly higher in the BEC group than in the RFC group at 4 weeks (17.6 % vs. 3.0 %) and at 6 months (11.8 % vs. 0.0 %); there were no significant differences at 12 months (8.8 % vs. 0.0 %). The RFC group had lower mean ESS scores at all time points. Mean VAS scores for runny nose or itchy nose showed better improvement in the RFC group. Mean VAS scores for postoperative pain were significantly lower in the RFC group at postoperative 4 weeks, as was the occurrence of nasal crusting. During the follow-up period, septal ulceration was seen in three patients at postoperative 6 months and septal perforation was observed in two patients at 12 months in the BEC group, whereas no septal necrosis or septal perforation occurred in the RFC group.</div></div><div><h3>Conclusions</h3><div>Both methods were effective for treating pediatric patients with RAE and AR. However, RFC was associated with a lower incidence of recurrent epistaxis, less crusting, lower postoperative pain, and fewer complications, implying that it may be the superior treatment.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"194 ","pages":"Article 112394"},"PeriodicalIF":1.2,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144072641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}